Page last updated: 2024-10-23

bisindolylmaleimide i and Hemolysis

bisindolylmaleimide i has been researched along with Hemolysis in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shkodra-Pula, B1
Grune, C1
Traeger, A1
Vollrath, A1
Schubert, S1
Fischer, D1
Schubert, US1

Other Studies

1 other study available for bisindolylmaleimide i and Hemolysis

ArticleYear
Effect of surfactant on the size and stability of PLGA nanoparticles encapsulating a protein kinase C inhibitor.
    International journal of pharmaceutics, 2019, Jul-20, Volume: 566

    Topics: Animals; Chickens; Drug Stability; Erythrocyte Aggregation; Erythrocytes; Hemolysis; Indoles; Maleim

2019